ArticleFrontiers in oncology2022

YY1-Targeted RBM15B Promotes Hepatocellular Carcinoma Cell Proliferation and Sorafenib Resistance by Promoting TRAM2 Expression in an m6A-Dependent Manner.

Chunzhong Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.